A Pilot Study of Calcipotriol as a Novel Treatment for Central Centrifugal Cicatricial Alopecia (CCCA)

• Status: Not yet recruiting
• Trial end date: 2023-07-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this pilot study is to determine if calcipotriol shows potential to be an effective treatment for Central Centrifugal Cicatricial Alopecia (CCCA). This study aims to evaluate calcipotriol due to the possible anti-inflammatory effects that may affect the hair growth cycle.

• Phase: Early Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Wake Forest University Health Sciences
• Treatments: Calcipotriene

Criteria

Inclusion Criteria:

• Women who are eighteen years of age or older

• biopsy-proven and/or clinical diagnosis of CCCA Stage II-IV

• must be on stable treatment without changes for at least 3 months

• Subjects will be recruited from outpatient dermatology clinics at the Wake Forest Baptist Health Department of Dermatology.

Exclusion Criteria:

• Males